Research Analysts Set Expectations for Express Scripts Holding Co’s FY2018 Earnings (ESRX)

Express Scripts Holding Co (NASDAQ:ESRX) – Investment analysts at Oppenheimer lowered their FY2018 earnings per share estimates for shares of Express Scripts in a research report issued to clients and investors on Wednesday, November 14th. Oppenheimer analyst M. Naidu now forecasts that the company will post earnings per share of $9.07 for the year, down from their prior forecast of $9.08. Oppenheimer also issued estimates for Express Scripts’ Q4 2018 earnings at $2.65 EPS, Q1 2019 earnings at $1.87 EPS and Q3 2019 earnings at $2.59 EPS.

Express Scripts (NASDAQ:ESRX) last announced its quarterly earnings data on Wednesday, October 31st. The company reported $2.43 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.42 by $0.01. Express Scripts had a net margin of 4.83% and a return on equity of 25.43%. The business had revenue of $25.56 billion during the quarter, compared to analyst estimates of $25.11 billion. During the same period last year, the firm posted $2.51 EPS. The company’s revenue was up 3.6% on a year-over-year basis.

A number of other equities research analysts have also issued reports on ESRX. Zacks Investment Research lowered shares of Express Scripts from a “hold” rating to a “sell” rating in a report on Monday, July 23rd. BidaskClub raised shares of Express Scripts from a “sell” rating to a “hold” rating in a report on Tuesday, July 31st. William Blair raised shares of Express Scripts from a “market perform” rating to an “outperform” rating in a report on Wednesday, August 1st. Royal Bank of Canada increased their price objective on shares of Express Scripts to $94.00 and gave the company an “outperform” rating in a report on Monday, August 27th. Finally, ValuEngine raised shares of Express Scripts from a “hold” rating to a “buy” rating in a report on Monday, September 17th. One research analyst has rated the stock with a sell rating, thirteen have given a hold rating, six have assigned a buy rating and one has given a strong buy rating to the company. The stock presently has a consensus rating of “Hold” and a consensus price target of $90.73.

Shares of ESRX opened at $97.64 on Monday. The company has a quick ratio of 0.65, a current ratio of 0.77 and a debt-to-equity ratio of 0.63. Express Scripts has a 1 year low of $60.63 and a 1 year high of $100.43. The company has a market cap of $55.06 billion, a price-to-earnings ratio of 13.75, a P/E/G ratio of 1.23 and a beta of 0.89.

Hedge funds have recently bought and sold shares of the stock. American National Registered Investment Advisor Inc. lifted its position in Express Scripts by 6.9% in the third quarter. American National Registered Investment Advisor Inc. now owns 7,825 shares of the company’s stock worth $743,000 after buying an additional 505 shares during the last quarter. Bank of Stockton lifted its position in Express Scripts by 5.2% in the third quarter. Bank of Stockton now owns 11,821 shares of the company’s stock worth $1,123,000 after buying an additional 581 shares during the last quarter. Utah Retirement Systems lifted its position in Express Scripts by 0.6% in the third quarter. Utah Retirement Systems now owns 104,514 shares of the company’s stock worth $9,930,000 after buying an additional 600 shares during the last quarter. Fieldpoint Private Securities LLC lifted its position in Express Scripts by 40.1% in the third quarter. Fieldpoint Private Securities LLC now owns 2,095 shares of the company’s stock worth $199,000 after buying an additional 600 shares during the last quarter. Finally, Busey Trust CO lifted its position in Express Scripts by 0.5% in the third quarter. Busey Trust CO now owns 114,461 shares of the company’s stock worth $10,874,000 after buying an additional 617 shares during the last quarter. 83.28% of the stock is owned by hedge funds and other institutional investors.

In related news, Director Mahon Thomas P. Mac sold 5,234 shares of the firm’s stock in a transaction on Wednesday, November 7th. The shares were sold at an average price of $99.50, for a total value of $520,783.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Company insiders own 0.79% of the company’s stock.

About Express Scripts

Express Scripts Holding Company operates as a pharmacy benefit management (PBM) company in the United States and Canada. The company's PBM segment offers clinical solutions; and specialized pharmacy care, home delivery and specialty pharmacy, retail network pharmacy administration, benefit design consultation, drug utilization review, drug formulary management, public exchange, administration of group purchasing organization, and digital consumer health and drug information services.

Read More: What is Compound Annual Growth Rate (CAGR)?

Earnings History and Estimates for Express Scripts (NASDAQ:ESRX)

Receive News & Ratings for Express Scripts Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply